Estrogen and progesterone receptor expression in the mammary gland tumors

被引：0

作者：

Moise, M. ^{[1
]}

Buruian, M. M. ^{[2
]}

Ilie, C. ^{[1
]}

Zamfir, Carmen Lacramioara ^{[3
]}

Folescu, Roxana ^{[1
]}

Motoc, A. G. M. ^{[1
]}

机构：

[1] Victor Babes Univ Med & Pharm, Dept Anat & Embryol, Timisoara 300041, Romania

[2] Univ Med & Pharm Tirgu Mures, Dept Radiol & Med Imaging, Targu Mures, Romania

[3] Grigore T Popa Univ Med & Pharm, Dept Morphofunct Sci, Discipline Histol, Iasi, Romania

来源：

ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY | 2013年 / 54卷 / 04期

关键词：

mammary; malignant tumor; estrogen; progesterone; receptor; BREAST-CANCER; NEOADJUVANT CHEMOTHERAPY; IMMUNOHISTOCHEMICAL DETECTION; CLINICAL-SIGNIFICANCE; HER2/NEU ONCOPROTEIN; PROLIFERATING CELLS; CARCINOMA; MAMMOGRAPHY; THERAPY; DISEASE;

D O I：

暂无

中图分类号：

Q [生物科学];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

In the primary mammary malignant tumors, including in situ carcinoma, it is recommended the carrying out of immunohistochemical diagnosis for the estrogen (ER) and the progesterone receptors (PR). We have studied the ER and the PR expression in malignant tumors, trying to identify the corresponding phenotypes according to the presence of these tumors. We have carried out a study on a total number of 80 carcinomas, divided into two groups: the first one constituted of 54 cases of carcinomas on which we had clinical data, and another group, constituted of 26 cases of mammary carcinoma, where no clinical data was available. We have observed that the values and the distribution of the ER and PR taken from the biopsies made in the patients with mammary carcinoma are influenced by the age and menopausal status. The combination of the ER/PR results lead to the definition of many tumoral phenotypes.

引用

页码：961 / 968

页数：8

共 21 条

[1] Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast [J].

Amano, G ;

Ohuchi, N ;

Ishibashi, T ;

Ishida, T ;

Amari, M ;

Satomi, S .

BREAST CANCER RESEARCH AND TREATMENT, 2000, 60 (01) :43-55

[2]

Amat S, 2002, INT J ONCOL, V20, P791

[3] Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer [J].

Berg, WA ;

Gutierrez, L ;

NessAiver, MS ;

Carter, WB ;

Bhargavan, M ;

Lewis, RS ;

Ioffe, OB .

RADIOLOGY, 2004, 233 (03) :830-849

[4] Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI [J].

Cheung, YC ;

Chen, SC ;

Su, MY ;

See, LC ;

Hsueh, S ;

Chang, HK ;

Lin, YC ;

Tsai, CS .

BREAST CANCER RESEARCH AND TREATMENT, 2003, 78 (01) :51-58

[5] Additional breast lesions in patients eligible for breast-conserving therapy by MRI: Impact on preoperative management and potential benefit of computerised analysis [J].

Deurloo, EE ;

Peterse, JL ;

Rutgers, EJT ;

Besnard, APE ;

Muller, SH ;

Gilhuijs, KGA .

EUROPEAN JOURNAL OF CANCER, 2005, 41 (10) :1393-1401

[6]

Enache DE, 2012, ROM J MORPHOL EMBRYO, V53, P755

[7]

Eremia IA, 2012, ROM J MORPHOL EMBRYO, V53, P811

[8] Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: Normal contrast medium enhancement and cyclical-phase dependency [J].

Kuhl, CK ;

Bieling, HB ;

Gieseke, J ;

Kreft, BP ;

Sommer, T ;

Lutterbey, G ;

Schild, HH .

RADIOLOGY, 1997, 203 (01) :137-144

[9] Locally advanced breast cancer: comparison of mammography, sonography and MR imaging in evaluation of residual disease in women receiving neoadjuvant chemotherapy [J].

Londero, V ;

Bazzocchi, M ;

Del Frate, C ;

Puglisi, F ;

Di Loreto, C ;

Francescutti, G ;

Zuiani, C .

EUROPEAN RADIOLOGY, 2004, 14 (08) :1371-1379

[10]

MacGrogan G, 1996, APPL IMMUNOHISTO M M, V4, P219

← 1 2 3 →